Harnessing Optimism and Perseverance in the Face of Long COVID-Español
Purpose
The Harnessing Optimism and Perseverance in the Face of Long COVID (HOPE-LC) program, created by Drs. Eric Watson and Amelia Hicks, is a group therapy model designed to foster resilience, adjustment, and coping skills for those living with chronic Long COVID. HOPE-LC~Español provides a culturally and linguistically adapted version for Spanish-speaking individuals in Queens, developed with input from Spanish-speaking clinicians, Long COVID experts, and people with lived experience. Partnering with H+H/Elmhurst and H+H/Queens, the project aims to recruit 25 participants and evaluate program feasibility and preliminary efficacy.
Condition
- Post-Acute COVID-19 Syndrome
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Age 18 years or older. - Speaks and understands Spanish at a level that allows active participation in group-based study procedures. - Self-reported history of Long COVID/post-COVID condition of any severity or duration, including ongoing emotional or cognitive symptoms affecting daily functioning or a medical professional has diagnosed you with a Long COVID/post-COVID condition of any severity or duration, including ongoing emotional or cognitive symptoms. - Ability to participate in group sessions either in-person or via telehealth (Zoom). - Willingness and capacity to provide informed consent.
Exclusion Criteria
- Presence of severe psychiatric conditions that would preclude participation in group therapy (e.g., active psychosis, suicidal intent requiring immediate intervention). - Inability to communicate in Spanish sufficiently to engage meaningfully in group sessions. - Cognitive or physical impairments prevent participation in group sessions or completion of surveys, without available accommodations. - Concurrent participation in another conflicting interventional trial targeting Long COVID symptoms.
Study Design
- Phase
- N/A
- Study Type
- Interventional
- Allocation
- N/A
- Intervention Model
- Single Group Assignment
- Intervention Model Description
- Single arm pre-post design. Focus is on feasibility with preliminary efficacy as secondary focus.
- Primary Purpose
- Treatment
- Masking
- None (Open Label)
- Masking Description
- Single arm
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
|
Experimental Patients Living with Chronic Long-COVID |
Spanish-speaking patients in the HOPE-LC program. |
|
Recruiting Locations
More Details
- NCT ID
- NCT07216040
- Status
- Not yet recruiting
- Sponsor
- Icahn School of Medicine at Mount Sinai
Detailed Description
The Harnessing Optimism and Perseverance in the Face of Long COVID (HOPE-LC) program, developed by Drs. Eric Watson (PI) and Amelia Hicks (co-I), is a 12-week online group therapy program tailored specifically to living with Long COVID as a chronic condition. HOPE-LC provides community and hope; fostering resilience, adjustment, and critical coping strategies in the face of this debilitating chronic condition. Since its inception in 2024, the HOPE-LC groups have engaged 20 patients, emphasizing the need for chronic Long COVID therapeutic interventions. Through HOPE-LC-Espanol the researchers will translate and adapt the HOPE-LC program into Spanish and expand HOPE-LC's reach to underserved Spanish-speaking communities in Queens and NYC. The aims are: (1) To translate and culturally adapt the HOPE-LC program for Spanish-speaking patients in collaboration with the Advisory Board of Spanish-speaking clinicians, Long COVID experts, and individuals with Long COVID lived experience; (2) In collaboration with the partners at H+H/Elmhurst and H+H/Queens, to conduct targeted recruitment to ensure the researchers are engaging specifically with local Hispanic/Latinx communities in Queens; and (3) To complete the HOPE-LC~Español program for 25 Spanish-speaking individuals experiencing Long COVID within the local Queens community. The researchers will evaluate program feasibility and treatment success to inform future scalability and sustainability as a clinical program.